The 2nd phase of MIT Enterprise Forum Poland took place at Adamed headquarters on Friday (24 August). During the meeting Paweł Wielgus, a member of our company’s management board, presented treatments for the most popular animal diseases and discussed plans related to the launch of biopharmaceuticals based on mesenchymal stem cells.